CDSCO panel rejects Optimus Pharma Phase III CT protocol of Tofacitinib Ointment for androgenic alopecia Medical Dialogues Team20 July 2022 12:30 PM GMTNew Delhi: Citing that there is no scientific rationality data and supportive published literature, the Subject Expert Committee (SEC) functional...
Androgenic alopecia linked to increased risk of metabolic syndrome: Study Medha Baranwal20 May 2022 2:30 PM GMTP.R. China: Androgenic alopecia (AGA) patients are at an increased risk of developing metabolic syndrome, and appropriate screening and counseling may...
Oral spironolactone safe and effective treatment for androgenic alopecia: Study Medha Baranwal12 Feb 2022 3:30 AM GMTUSA: Oral spironolactone, both as monotherapy and in combination with topical minoxidil, is a safe and effective treatment for women with androgenetic...
Dr Reddys Minoxidil gets CDSCO panel nod to treat androgenic alopecia in females Medical Dialogues Team23 Aug 2021 11:21 AM GMTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Dr Reddy's...
Hair loss is not loss of hope- Latest management options Dr Manoj Kumar Nayak29 July 2021 4:30 AM GMTHair loss is not loss of hope, asserts a review of management options.Hair loss is a common complaint of dermatologic patients which may be due to...
Low dose Oral Minoxidil Safe for Non-scarring Alopecia, finds study Dr.Niharika Harsha B4 July 2020 3:00 AM GMTMinoxidil was first discovered to treat Hypertension but with its adverse effect of hypertrichosis in bald patients, a topical formulation was...
